Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients

Objective: Anti-CD20-treated patients are at risk of a reduced humoral immune response during the SARS-CoV-2 pandemic. Our aim was to compare the antibody response after two vaccinations with the mRNA vaccines BNT162b2 or mRNA-1273 in patients with multiple sclerosis. Methods: Data from the Universi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammer, Helly, Hoepner, Robert, Friedli, Christoph, Leib, Stephen L., Suter-Riniker, Franziska, Diem, Lara, Kamber, Nicole, Chan, Andrew, Salmen, Anke, Kamm, Christian P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229998/
https://www.ncbi.nlm.nih.gov/pubmed/35746529
http://dx.doi.org/10.3390/vaccines10060922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229998/
https://www.ncbi.nlm.nih.gov/pubmed/35746529
http://dx.doi.org/10.3390/vaccines10060922

Ejemplares similares